Launch of Gnomica Biotherapy

10 June, 2025

We are proud to announce the launch of Gnomica Biotherapy, a new biotech company emerging from discoveries made in Ravid Straussman's lab at the Weizmann Institute of Science!

Gnomica is pioneering a novel approach to cancer treatment, developing small-molecule drug inhibitors targeting bacterial functions in the human body, a critical and often overlooked factor in treatment resistance.

Read more

Quantum Art to Advance Scalable Quantum Computing Through Logical Qubit Compiler and NVIDIA CUDA-Q Integration

11 June, 2025

Quantum Art to Advance Scalable Quantum Computing Through Logical Qubit Compiler and NVIDIA CUDA-Q Integration

The latest advancements in quantum computing, including a new logical qubit compiler and integration with NVIDIA CUDA-Q, are set to significantly boost the scalability of quantum systems.

This is a huge leap forward for the industry, paving the way for more powerful and accessible quantum solutions.

Read more

UltraSight™ Receives KFDA Regulatory Approval for AI Guidance System, Expanding Global Access to Cardiac Imaging

09 June, 2025

UltraSight™ Receives KFDA Regulatory Approval for AI Guidance System, Expanding Global Access to Cardiac Imaging

Read more

Top 60 - Non-profit research institutes and Government agencies granted US utility patents

05 June, 2025
TOP 60 - Non-profit research institutes and Government agencies granted US utility patents
Read more

Phytolon and Ginkgo Bioworks announce natural food colour production milestone

02 May, 2025

Biotech start-ups Phytolon and Ginkgo Bioworks have announced the successful completion of the second development milestone in their multi-product collaboration to produce natural food colours.

Read more

ProFuse Announces New Drug Development Platform for Muscle Loss Prevention Medication

07 April, 2025

Weight loss is a serious issue amongst Americans. While obesity is the main condition related to this issue, weight loss is also a major concern for many patients. It’s not uncommon for people to lose weight either directly from being sick or as a side effect of medication.

Read more

UltraSight to Expand Access to Echocardiographic Monitoring for Obstructive Hypertrophic Cardiomyopathy Patients

11 February, 2025

UltraSight, a spinoff company of Yeda, Expands Access to Echocardiographic Monitoring for Obstructive Hypertrophic Cardiomyopathy Patients
“By applying the power of machine learning to imaging, our aim is to streamline patient cardiac workflows for better, more efficient, and effective care” (Davidi Vortman, CEO)

Read more

80 Acres Farms Announces 2024 Capital Raises and Acquisitions

10 February, 2025

80 Acres Farms announced capital raises totaling $115 million and the acquisition of Plantae Biosciences, a spinoff company of YEDA.
The acquisition of Plantae Biosciences brings innovative plant breeding technology to 80 Acres Farms and its technology-focused subsidiary, Infinite Acres.
Since 2020, Plantae has collaborated with the Weizmann Institute of Science on projects in accelerated plant breeding via an exclusive license agreement with Yeda. The world-class researchers who built Plantae are now operating as Infinite Acres Israel.

Read more

Yeda's Newsletter 01/2025

10 January, 2025

This edition highlights the activities of the Weizmann Innovation Nest (WIN), a cornerstone in transitioning groundbreaking research from the lab to impactful real-world applications. Additionally, it showcases the latest technological advancements, laboratory innovations, and spinoff companies emerging from the Weizmann Institute of Science.

Read more

Packaged Feeds partners with FreezeM to advance zero-waste insect farming

05 February, 2025

Packaged Feeds has partnered with FreezeM, a spinoff company of YEDA, to incorporate its PauseM product - a solution containing suspended black soldier fly (BSF) neonates with a 14-day shelf life - into its insect farming process.

Read more

Pages

Subscribe to YEDA Technology Transfer RSS